Compound E, chemically designated as 209986-17-4 (CAS), represents a significant exploration within the field of Alzheimer's illness research. This γ-secretase blocking agent was initially developed as a possible https://prestonkhfb301415.blog-gold.com/57406341/γ-secretase-blocker-compound-e-209986-17-4